| EPB019 | Adherence and resistance to ART among postpartum women with HIV in KwaZulu-Natal, South Africa | E-poster | Viral load and CD4 monitoring |
| EPB020 | Know your numbers: a catalyst to improve viral load coverage in Western Region of Ghana | E-poster | Viral load and CD4 monitoring |
| EPB021 | Pilot of HIV viral load testing using plasma samples in poor resources settings in Malawi: challenges and lessons learned | E-poster | Viral load and CD4 monitoring |
| EPLBB09 | Risk factors and prognoses for low-level HIV-1 viremia: a long-time observational study | E-poster | Viral load and CD4 monitoring |
| OALBB0105 | Incident tuberculosis as a risk factor for viral non-suppression 48 weeks among patients switched to dolutegravir based therapy with recycled nucleoside reverse transcriptase inhibitors in Lusaka, Zambia | Oral abstract session with live Q&A | Viral load and CD4 monitoring |
| PESAB04 | Comparison of Advanced HIV Disease identification using CD4 results from a semi-quantitative CD4 point of care test and CD4 flow cytometry in Nigeria | Poster exhibition | Viral load and CD4 monitoring |
| EPB051 | Understanding unsuccessful direct-acting antiviral hepatitis C treatment among people living with HIV from the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHECH) | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB052 | Acute HCV infection followed by spontaneous clearance impact on telomere shorting | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB053 | A cluster randomized controlled studyofsecondary distribution of HCV self-test to support micro-elimination in Karachi, Pakistan | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPB054 | Hepatitis B prevalence and risk factors among adults living with HIV in South Africa | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |